Delivery Order SPE2DB24D2205-SPE2DB24FDVKK
Award Date
6/11/24
Potential Completion Date
6/12/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The contract has a ceiling value of $20,898.72 and a completion date of July 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,544.68 and is a firm fixed-price delivery order with an ultimate completion date of October 11, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides the Defense Logistics Agency (DLA) with delivery orders for Ozempic, a prescription medication for the treatment of diabetes. The contract has a ceiling value of $10,449.72 and will run through May 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to deliver a range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of Ozempic, a prescription medication, at a ceiling value of $1,741.62. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. Amerisourcebergen, a major pharmaceutical distributor in the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $4,350.63 firm-fixed-price delivery order has a completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL pharmaceutical products. The award is a Firm Fixed Price Delivery Order with a ceiling value of $25,982.82 and a completion date of September 5, 2024. Amerisourcebergen, a major supplier of pharmaceutical and medical products to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML to the Defense Logistics Agency (DLA). The $6,966.24 firm-fixed-price delivery order has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company...
This federal contract award to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, is for the delivery of Ozempic, a diabetes medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,822.72 and a completion date of September 11, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a potential value of up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 0.25-0.5mg 1s, a pharmaceutical product, to the Department of Defense (DoD) and other government agencies. The single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, and serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic, a medication used to treat diabetes, with a ceiling value of $45,502.18. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 17, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...